ARZNEIWERK AG VIDA: Navigating Telecom Roots & Pharma Pivot Amid Volatile Markets
ARZNEIWERK AG VIDA pivots from telecom to pharma, but its volatile stock and negative P/E show risks; can data‑driven strategy secure its future?
3 minutes to read
ARZNEIWERK AG VIDA